Tag: Piramal Pharma

Stocks that will see action today: 15 July 2024

Fitch Ratings has revised the outlook on India-based Tata Steel Ltd’s (TSL) Issuer Default Rating (IDR) to Negative, from Stable,

The company also reported a year-on-year improvement in demand for their generic API business | Photo: Twitter Pharmaceutical company Piramal

India’s market regulator, seeking to reduce risks for retail investors, will propose linking the amount of equity derivatives they may

Adani New Industries, an arm of Adani Enterprises, on Thursday raised $394 million (₹3,231 crore) from Barclays PLC and Deutsche

Skipper has accumulated profits totaling Rs. 1,135 crore for the design, supply and construction of new transmission line projects for

CDPQ on Friday liquidated 0.89 per cent stake in Piramal Pharma Ltd for Rs 100 crore through an open market

Adani for green energy The company said in a statement on the stock exchange that it canceled the meeting of

Target: 114 rupees CMP: INR 72.42 In the third quarter and the first nine months of fiscal ’23, the company